Discovery of molecular subtypes in leiomyosarcoma through integrative molecular profiling

[1]  Joon-Oh Park,et al.  Expression of MET in alveolar soft part sarcoma , 2010, Medical oncology.

[2]  Andrew H. Beck,et al.  Gene expression profiling for the investigation of soft tissue sarcoma pathogenesis and the identification of diagnostic, prognostic, and predictive biomarkers , 2010, Virchows Archiv.

[3]  Andrew H. Beck,et al.  Coordinate expression of colony-stimulating factor-1 and colony-stimulating factor-1-related proteins is associated with poor prognosis in gynecological and nongynecological leiomyosarcoma. , 2009, The American journal of pathology.

[4]  O. Mariani,et al.  Strong smooth muscle differentiation is dependent on myocardin gene amplification in most human retroperitoneal leiomyosarcomas. , 2009, Cancer research.

[5]  F. Lo‐Coco,et al.  Identification of a potential “hotspot” DNA region in the RUNX1 gene targeted by mitoxantrone in therapy‐related acute myeloid leukemia with t(16;21) translocation , 2009, Genes, chromosomes & cancer.

[6]  Andrew H. Beck,et al.  The Macrophage Colony-Stimulating Factor 1 Response Signature in Breast Carcinoma , 2009, Clinical Cancer Research.

[7]  S. Knuutila,et al.  Does comparative genomic hybridization reveal distinct differences in DNA copy number sequence patterns between leiomyosarcoma and malignant fibrous histiocytoma? , 2008, Cancer genetics and cytogenetics.

[8]  K. Landis-Piwowar,et al.  Relationship between the methylation status of dietary flavonoids and their growth‐inhibitory and apoptosis‐inducing activities in human cancer cells , 2008, Journal of cellular biochemistry.

[9]  B. Spiegelman,et al.  PRDM16 controls a brown fat/skeletal muscle switch , 2008, Nature.

[10]  F. Farrokhyar,et al.  A systematic meta‐analysis of randomized controlled trials of adjuvant chemotherapy for localized resectable soft‐tissue sarcoma , 2008, Cancer.

[11]  Robert J. Marinelli,et al.  Prognostic Significance of Macrophage Infiltration in Leiomyosarcomas , 2008, Clinical Cancer Research.

[12]  R. Tibshirani,et al.  Spatial smoothing and hot spot detection for CGH data using the fused lasso. , 2008, Biostatistics.

[13]  Weidong Wang.  Emergence of a DNA-damage response network consisting of Fanconi anaemia and BRCA proteins , 2007, Nature Reviews Genetics.

[14]  C. Sotiriou,et al.  Taking gene-expression profiling to the clinic: when will molecular signatures become relevant to patient care? , 2007, Nature Reviews Cancer.

[15]  Tsutomu Ohta,et al.  Gene expression analysis of soft tissue sarcomas: characterization and reclassification of malignant fibrous histiocytoma , 2007, Modern Pathology.

[16]  P. Pandolfi,et al.  The AKT-mTOR pathway plays a critical role in the development of leiomyosarcomas , 2007, Nature Medicine.

[17]  Amy V Kapp,et al.  Are clusters found in one dataset present in another dataset? , 2007, Biostatistics.

[18]  O. Myklebost,et al.  Diagnostic and prognostic gene expression signatures in 177 soft tissue sarcomas: hypoxia-induced transcription profile signifies metastatic potential , 2007, BMC Genomics.

[19]  S. Devesa,et al.  Incidence patterns of soft tissue sarcomas, regardless of primary site, in the surveillance, epidemiology and end results program, 1978–2001: An analysis of 26,758 cases , 2006, International journal of cancer.

[20]  H. Dressman,et al.  Genomic signatures to guide the use of chemotherapeutics , 2006, Nature Medicine.

[21]  O. Myklebost,et al.  Array comparative genomic hybridization reveals distinct DNA copy number differences between gastrointestinal stromal tumors and leiomyosarcomas. , 2006, Cancer research.

[22]  R. Tibshirani,et al.  Sparse Principal Component Analysis , 2006 .

[23]  P. Meltzer,et al.  Gene expression profiling of human sarcomas: insights into sarcoma biology. , 2005, Cancer research.

[24]  C. Perou,et al.  Molecular portraits and 70-gene prognosis signature are preserved throughout the metastatic process of breast cancer. , 2005, Cancer research.

[25]  Neil Sebire,et al.  A molecular map of mesenchymal tumors , 2005, Genome Biology.

[26]  R. Hoda,et al.  Rosai and Ackerman???s Surgical Pathology , 2004 .

[27]  C. Cooper,et al.  A Gene Expression Signature Associated with Metastatic Outcome in Human Leiomyosarcomas , 2004, Cancer Research.

[28]  Fausto J. Rodriguez,et al.  Rosai and Ackerman’s Surgical Pathology, 9th ed. , 2004 .

[29]  P. Cin,et al.  Molecular pathogenesis of uterine smooth muscle tumors from transcriptional profiling , 2004, Genes, chromosomes & cancer.

[30]  L. J. Veer,et al.  Hard Wired Genotype in Metastatic Breast Cancer , 2004, Cell cycle.

[31]  R. Tibshirani,et al.  Use of gene-expression profiling to identify prognostic subclasses in adult acute myeloid leukemia. , 2004, The New England journal of medicine.

[32]  M. Zollo,et al.  Unraveling Genes and Pathways Influenced by H-Prune PDE Overexpression: A Model to Study Cellular Motility , 2004, Cell cycle.

[33]  R. Tibshirani,et al.  Gene expression profiling identifies clinically relevant subtypes of prostate cancer. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[34]  T. Thompson,et al.  Caveolin-1 Maintains Activated Akt in Prostate CancerCells through Scaffolding Domain Binding Site Interactions with andInhibition of Serine/Threonine Protein Phosphatases PP1 andPP2A , 2003, Molecular and Cellular Biology.

[35]  P. Meltzer,et al.  Mechanisms of sarcoma development , 2003, Nature Reviews Cancer.

[36]  A. Skubitz,et al.  Differential gene expression in leiomyosarcoma , 2003, Cancer.

[37]  William Stafford Noble,et al.  Classification and subtype prediction of adult soft tissue sarcoma by functional genomics. , 2003, The American journal of pathology.

[38]  C. Mathew,et al.  Acquired FANCA dysfunction and cytogenetic instability in adult acute myelogenous leukemia. , 2003, Blood.

[39]  Y. Yu,et al.  Gene expression analysis of human soft tissue leiomyosarcomas. , 2003, Human pathology.

[40]  P. Meltzer,et al.  Soft tissue sarcomas of adults: state of the translational science. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[41]  E. Lander,et al.  A molecular signature of metastasis in primary solid tumors , 2003, Nature Genetics.

[42]  N. O’Callaghan,et al.  CBFA2T3 (MTG16) is a putative breast tumor suppressor gene from the breast cancer loss of heterozygosity region at 16q24.3. , 2002, Cancer research.

[43]  R. Tibshirani,et al.  Diagnosis of multiple cancer types by shrunken centroids of gene expression , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[44]  D. Botstein,et al.  For Personal Use. Only Reproduce with Permission from the Lancet Publishing Group , 2022 .

[45]  Ilya Shmulevich,et al.  Tumor specific gene expression profiles in human leiomyosarcoma , 2002, Cancer.

[46]  David Sidransky,et al.  Emerging molecular markers of cancer , 2002, Nature Reviews Cancer.

[47]  M. Kattan,et al.  Postoperative nomogram for 12-year sarcoma-specific death. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[48]  Alex E. Lash,et al.  Gene Expression Omnibus: NCBI gene expression and hybridization array data repository , 2002, Nucleic Acids Res..

[49]  René Bernards,et al.  A progression puzzle. , 2002, Nature.

[50]  F. Mertens,et al.  World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Soft Tissue and Bone , 2002 .

[51]  E. Mindell.  Enzinger and Weiss’s Soft Tissue Tumors. 4th ed. , 2001 .

[52]  A. Ashworth,et al.  Microarray and histopathological analysis of tumours: the future and the past? , 2001, Nature Reviews Cancer.

[53]  R. Tibshirani,et al.  Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[54]  J. Goldblum,et al.  Enzinger and Weiss's Soft Tissue Tumors , 2001 .

[55]  R. Tibshirani,et al.  Significance analysis of microarrays applied to the ionizing radiation response , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[56]  Ash A. Alizadeh,et al.  Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling , 2000, Nature.

[57]  Adjuvant chemotherapy for localised resectable soft tissue sarcoma in adults. , 2000, The Cochrane database of systematic reviews.

[58]  G. V. Vande Woude,et al.  Met expression and sarcoma tumorigenicity. , 1993, Cancer research.